ERVW-1 and HIV-1 infection: Despite this early “hypothesis generating” finding in this first promising HIV-1 vaccine trial, the importance of the diversity of antibodies elicited by other epitopes on Env such as the CD4i epitope(s) [71], during infection and vaccination, and their role in immune protection against HIV-1 infection warrant further investigation.